Purpose. To review 437 hips in 404 patients who underwent total hip arthroplasty (THA) or hemiarthroplasty using the Accolade TMZF stem to determine the incidence and risk factors of distal femoral cortical hypertrophy (DFCH). Methods. Records of 437 hips in 169 men and 235 women aged 26 to 100 (mean, 65.7) years who underwent THA (n=293) or hemiarthroplasty (n=144) using the Accolade TMZF femoral stem by 2 senior surgeons and were followed up for a mean of 54.7 months were reviewed. Clinical outcome was assessed using the modified Harris Hip Score and visual analogue score for pain. Proximal femoral geometry and canal flare index were assessed on preoperative radiographs, and DFCH, stem position, subsidence, loosening, and stress shielding were assessed on postoperative radiographs according to the Gruen zone. Results. Of 437 hips, 27 (6.2%) developed DFCH and 410 did not. Hips with DFCH had a higher incidence of thigh pain (18.5% vs. 2.2%, p<0.001) and earlier onset Distal femoral cortical hypertrophy after hip arthroplasty using a cementless doubletapered femoral stem
of thigh pain (12.3 vs. 20.8 months, p=0.015), compared with those without. Nonetheless, all femoral stems were well-fixed, and no osteolysis or loosening was detected. The 2 groups achieved comparable clinical outcome in terms of Harris Hip Score and pain. The mean canal flare index was higher in hips with than without DFCH (3.706 vs. 3.294, p=0.002). The mean vertical subsidence of the femoral stem was lower in hips with than without DFCH (1.5 vs. 3.4 mm p<0.001). Subsidence negatively correlated with the canal flare index (correlation coefficient= -0.110, p=0.022). The incidence of the DFCH increased with each unit of increment in canal flare index (odds ratio [OR]=1.828, p=0.043) and each year younger in age (OR=0.968, p=0.015). Conclusion. The incidence of DFCH in hips with the Accolade TMZF stem was 6.2%. Patients with a higher canal flare index and younger age had a higher incidence of DFCH. Nonetheless, DFCH did not affect clinical outcome or femoral stem stability.
introduction Total hip arthroplasty (THA) is a successful orthopaedic procedure. 1, 2 Nonetheless, bone remodelling around the femoral stem may affect its long-term survival. 3, 4 Unloading of the proximal femur is associated with increased bone strain at the femoral stem tip, [5] [6] [7] which may cause distal femoral cortical hypertrophy (DFCH)-fusiform enlargement of cortical bone in the femoral stem tip. [8] [9] [10] [11] [12] Excess stress on bone from the femoral stem tip can cause thigh pain even in a well-fixed cementless THA. 13, 14 DFCH and stress shielding are more pronounced with a large and stiff femoral stem. [15] [16] [17] The Accolade TMZF stem (Stryker, Mahwah [NJ], USA) is a double-tapered, wedge-type cementless design with a hydroxyapatite (HA) coating to improve initial fixation and stress transfer with a 25% lower modulus of elasticity, compared with stems made of standard titanium alloy. 18, 19 This study reviewed 437 hips in 404 patients who underwent THA or hemiarthroplasty using the Accolade TMZF stem to determine the incidence and risk factors of DFCH.
Materials and Methods
Records of 437 hips in 169 men and 235 women aged 26 to 100 (mean, 65.7) years who underwent THA (n=293) or hemiarthroplasty (n=144) using the Accolade TMZF femoral stem by 2 senior surgeons between June 2006 and March 2012 and were followed up for a mean of 54.7 (range, 24.3-91.7) months were reviewed. The diagnosis included fracture (n=169), secondary osteoarthritis (n=137), avascular necrosis of the femoral head (n=109), and primary osteoarthritis (n=22). Patients with previous hip surgery or incomplete records or radiographs were excluded, as were those who underwent subsequent revision surgery.
Postoperative rehabilitation was standardised. Partial weight bearing with crutches or a walker was allowed as tolerated immediately after surgery. Full weight bearing was allowed at 3 months.
Patients were followed up at 3, 6, and 12 months and yearly thereafter. Clinical outcome was assessed using the modified Harris Hip Score 20 and visual analogue score for pain. Radiographic outcome was independently assessed by one senior surgeon and one resident on 2 occasions >2 months apart. Proximal femoral geometry and canal flare index (the ratio of the diameter of the femoral canal at the isthmus in the anteroposterior view to the diameter of the medullary canal 20 mm above the lesser trochanter) were assessed on preoperative radiographs, 21 and DFCH, stem position, subsidence, loosening, and stress shielding were assessed on postoperative radiographs according to the Gruen zone. Intraclass correlation coefficient was used to determine interand intra-observer reliability, which were 0.86 and 0.89, respectively, for subsidence measurement.
The paired t-test was used to compare pre-and post-operative outcome. The Mann-Whitney U test and Pearson Chi-squared test were used to compare hips with and without DFCH for continuous and discrete variables, respectively. Logistic regression analysis was used to identify risk factors for DFCH. A p value of <0.05 was considered statistically significant.
results
Of 437 hips, 27 (6.2%) developed DFCH and 410 did not. Table 1 ]. Among the 5 hips with both DFCH and thigh pain, the onset of thigh pain preceded the onset of DFCH (12.3 vs. 18.1 months), and the duration of thigh pain was shorter than the progression of DFCH (18.9 vs. 40.2 months) [ Table 2 ]. Nonetheless, all femoral stems were well-fixed, and no osteolysis or loosening was detected. The 2 groups achieved comparable clinical outcome in terms of Harris Hip Score and pain.
Among the 27 hips with DFCH, proximal femoral geometry was proportional in 13 hips, champagneflute type in 7 hips, and stove-pipe type in 7 hips. DFCH developed in Gruen zones II to III and V to VI in 9 hips, zone II in 8 hips, zone V in 7 hips, and zone VI in 3 hips (Fig. 1) . The femoral stem position was neutral in 22 hips and valgus in 5 hips. In hips with a valgus-positioned stem, DFCH predominantly developed in zone II (Fig. 2 ). Stress shielding developed in 17 hips, all in zone I.
The mean canal flare index was higher in hips with than without DFCH (3.706 vs. 3.294, p=0.002). The mean vertical subsidence of the femoral stem was lower in hips with than without DFCH (1.5 vs. 3.4 mm p<0.001). Subsidence negatively correlated with the canal flare index (correlation coefficient= -0.110, p=0.022). Table 3 ].
discussion
The aetiology of bone remodelling such as calcar resorption and DFCH after THA is multifactorial. 22 Nonetheless, the main cause is abnormal load transmitted from the stem to bone. 5, 23 Strain is maximum around the stem tip rather than at the calcar area in a cemented femoral component. 24 This can cause resorption in the calcar region and cortical hypertrophy distally. 24 Proximal bone loss increases the distal load and affects implant fixation, and high bending stiffness may be related to thigh pain and DFCH. 25, 26 The β-type Ti-alloy stem has lower axial and bending stiffness than the Ti-6AI-4V stem; this minimises proximal femoral bone loss and distal load and biological fixation, and improves long-term stability. 27 * Data are presented as mean±SD (range), mean (range), or no. (%) of hips 
Table 3 Logistic regression analysis for distal femoral cortical hypertrophy
In one study, 3.4% of hips with a cementless stem developed DFCH, and stainless steel stems were most prone to DFCH. 8 In another study, 49% and 27% of patients with straight stem and anatomic proximal porous coated stems developed DFCH, respectively. 28 In our study, 6.2% of hips developed DFCH. The difference in the incidence of DFCH among studies may be due to different load transfer generated from different stem geometries and fixation locations or the porous coating extension or titanium alloy. The Accolade TMZF stem is a double-tapered, wedgetype, short, cementless design, with metaphyseal fixation and made of the β-type Ti-alloy. It decreases stress shielding and the incidence of DFCH and thigh pain owing to more physiological load transfer.
Stem subsidence may be due to poor initial stability and affects long-term survival of the stem. In one study, 5.2% of patients developed cemented stem subsidence that was associated with stem loosening. 15 In another study, all patients developed stem subsidence of <4 mm, but no patients had aseptic loosening. 29 In hips with the Accolade stem, the mean subsidence was 1.3 mm at 24 months, and 36% of stems subsided ≥1.5 mm. 19 In our study, mean overall subsidence was 3.4 mm after a mean of 54.7 months, but no stem loosening was detected. The mean subsidence was lower in hips with than without DFCH (1.5 vs. 3.4 mm, p=0.001). The prevalence of stem subsidence is lower in patients with DFCH than those without. 8, 15 This may be due to tight initial fixation of the distal stem tip that decreases subsidence but increases distal loading and results in DFCH.
The incidence of thigh pain in hips with a cementless stem has been reported to be 0.5 to 49%. [30] [31] [32] [33] [34] The potential causes of thigh pain include bone prosthesis micromotion, excessive stress transfer to the femur, and a mismatch in Young's modulus of elasticity. 26 In our study, the incidence of thigh pain was 18.5% in hips with DFCH and 2.2% in hips without DFCH. The thigh pain usually preceded DFCH suggesting that tight initial fixation of the distal stem tip to the femur could lead to excess load transfer to the femur, thigh pain, and DFCH. Nonetheless, the clinical outcome of the 2 groups was comparable, and there was no evidence to indicate association of DFCH with poor outcome. In our study, the incidence of DFCH increased with increasing canal flare index and decreasing age. DFCH occurred more often in younger patients because they have a higher canal flare index (champagne-flute type) and a thicker diaphyseal cortex and good bony quality than older patients. This results in tight fixation of the stem in the diaphysis and increases distal loading and thus DFCH.
Our study had limitations. Although the number of patients was relatively large, the follow-up was short and the study was retrospective. The number of hips with DFCH was too small compared with the number of hips without DFCH.
conclusion
The incidence of DFCH in hips with the Accolade TMZF stem was 6.2%. Patients with a higher canal flare index and younger age had a higher incidence of DFCH. Nonetheless, DFCH did not affect clinical outcome or femoral stem stability.
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